Text Size

Skin Aging in Renal Transplant Patients

This study is enrolling participants by invitation only.
Sponsor:
Information provided by (Responsible Party):
University of Zurich
ClinicalTrials.gov Identifier:
NCT01776983
First received: January 24, 2013
Last updated: January 28, 2013
Last verified: January 2013
History of Changes
  Purpose

Determination of collagen, pigment and haemoglobin content of sun exposed and sun protected skin by Siascopy. Immunocompromised patients (for more than seven years) compared to immunocompetent patients.

  • Trial in the field of transplantation / xenotransplantation

Condition Intervention Phase
Photosensitivity Disorders
 Device: Photosensitivity under the influence of immunocomp
 Phase 4

Study Type: Observational
Study Design: Observational Model: Cohort
Official Title: Skin Aging in Renal Transplant Patients

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by University of Zurich:

Primary Outcome Measures:
  • skin aging defined by melanin, collagen and hemoglobin content [ Designated as safety issue: No ]

Enrollment: 100
Study Start Date: September 2008
Estimated Study Completion Date: March 2014
Estimated Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)
Intervention Details:
    Device: Photosensitivity under the influence of immunocomp
    Siascopy measurement of reflected light
Detailed Description:

Determination of collagen, pigment and haemoglobin content of sun exposed and sun protected skin by Siascopy. Immunocompromised patients (for more than seven years) compared to immunocompetent patients.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

individuals between 18 and 90 years of age

Criteria

Inclusion criteria:

  • Renal transplant recipients transplanted more than seven years ago and immunocompetent probands of the same age.

Exclusion criteria:

  • Refusal of informed consent, physical or psychological inability to give informed consent.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01776983

Locations
Switzerland
University Hospital Zurich, Department of Dermatology
Zurich, ZH, Switzerland, 8091
Sponsors and Collaborators
University of Zurich
Investigators
Principal Investigator: Günther Hofbauer, MD University Hospital Zurich, Department of Dermatology
  More Information

No publications provided

Responsible Party: University of Zurich
ClinicalTrials.gov Identifier: NCT01776983     History of Changes
Other Study ID Numbers: 2008SIA01
Study First Received: January 24, 2013
Last Updated: January 28, 2013
Health Authority: Switzerland: Swissmedic

Additional relevant MeSH terms:
Photosensitivity Disorders
Dermatitis, Phototoxic
Epilepsy, Reflex
Skin Diseases
Dermatitis, Irritant
Dermatitis, Contact
 Dermatitis
Skin Diseases, Eczematous
Epilepsy
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases

ClinicalTrials.gov processed this record on May 16, 2013